KSIOF:OTC-kneat.com inc. (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 3.45

Change

+0.01 (+0.29)%

Market Cap

USD 0.31B

Volume

1.90K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in various applications, including document management, analytical instrument validation, method validation, commissioning and qualification, drawing management, utility and facility validation, cold chain validation, electronic logbook management, process validation, computer system validation, and cleaning validation. The company also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
PMCUF Pro Medicus Limited

-3.81 (-3.20%)

USD 12.25B
MTHRY M3 Inc

-0.02 (-0.29%)

USD 6.94B
SMSZF SMS Co. Ltd

N/A

USD 1.52B
PANHF Ping An Healthcare and Technol..

N/A

USD 1.43B
SMSSY SMS Co., Ltd.

-0.18 (-2.24%)

USD 1.33B
CRWRF Craneware plc

N/A

USD 1.07B
SUSRF Surgical Science Sweden AB (pu..

N/A

USD 0.61B
SFSVF Software Service, Inc.

N/A

USD 0.50B
VHIBF Vitalhub Corp

N/A

USD 0.34B
COGZF Cogstate Limited

N/A

USD 0.11B

ETFs Containing KSIOF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 50.00% 76% C+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.00% 76% C+ 85% B
Trailing 12 Months  
Capital Gain 53.01% 79% B- 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.01% 79% B- 83% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.88% 64% D 62% D
Dividend Return 16.88% 63% D 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.80% 94% A 83% B
Risk Adjusted Return 77.42% 97% N/A 96% N/A
Market Capitalization 0.31B 87% B+ 65% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector